PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan; Department of Infection Control and Prevention, Aichi Medical University Hospital, Japan.\', \'Department of Infection Control and Prevention, Aichi Medical University Hospital, Japan.\', \'Division of Biostatistics, Clinical Research Center, Aichi Medical University Hospital, Japan.\', \'Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan; Department of Emergency and Critical Care Medicine, Aichi Medical University Hospital, Japan.\', \'Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan; University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane & Women\'s Hospital, Brisbane, QLD, Australia.\', \'Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan; Department of Molecular Epidemiology and Biomedical Sciences, Aichi Medical University, Aichi, Japan.\', \'Department of Clinical Infectious Diseases, Aichi Medical University Hospital, Aichi, Japan; Department of Infection Control and Prevention, Aichi Medical University Hospital, Japan. Electronic address: mikamo@aichi-med-u.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1341-321X(20)30330-510.1016/j.jiac.2020.09.010
?:doi
?:hasPublicationType
?:journal
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 32994136
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Could threshold cycle value correctly reflect the severity of novel coronavirus disease 2019 (COVID-19)?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all